Clinical Trial 12750

San Antonio, TX 78209


Study Summary:

ICON Development Solutions is conducting a research study in healthy men and women ages 18-55.

This study is being done to evaluate the delivery method, safety and tolerability of an investigational drug that is being developed for the treatment of allergic diseases. The study drug will be given as a single injection in the abdomen.

Vital signs, ECGs, and physical examinations will be performed, and blood and urine samples will be obtained during this study.


Qualified Participants Must:

• Be between the ages of 18 and 55
• Weigh between 60.0 and 80.0 kg, or 132 and 176 lbs
• Have a BMI between 20 and 30 kg/m2
• Be healthy, with no known or suspected infections or health conditions
• If female, not be pregnant or breast feeding
• Be a nonsmoker
• Not have participated in any other clinical study in the past 30 days prior to the start of this study
• Not have any hypersensitivity to doxycycline or any tetracycline drugs
• Complete 1 screening visit, 1 overnight stay and 13 outpatient visits


Qualified Participants May Receive:

All study related exams at no cost and compensation up to $1,850 for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.